Has Caitlin Borriello received payments from drug or device companies?

Yes. Drug and device makers reported $3,642 in general payments to Caitlin Borriello across 115 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Caitlin Borriello did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Caitlin Borriello come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Caitlin Borriello

Nurse Practitioner · Commack, NYNPI 1134578750

Payments from drug & device makers

$3,642in general payments, 2019–2025

Across 115 payments — averaging $31.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Novartis$409
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$289
E.r. Squibb & Sons, L.L.C.$211
Bayer$137
AstraZeneca$135
plus $571 from 11 others

What the payments were for

Food & beverage$3,642100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	58	$1,889
Novartis	18	$409
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$289
E.r. Squibb & Sons, L.L.C.	6	$211
Bayer	2	$137
AstraZeneca	2	$135
Regeneron Healthcare Solutions, Inc.	4	$104
Scpharmaceuticals Inc.	4	$100
Merck	5	$89
Alnylam Pharmaceuticals Inc.	2	$59
Daiichi Sankyo Inc.	2	$45
United Therapeutics Corporation	2	$39
Endotronix, Inc.	1	$31
ANI Pharmaceuticals, Inc.	1	$30
Lexicon Pharmaceuticals, Inc.	1	$28
Pfizer	1	$25
Sanofi-aventis U.S. LLC	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,642 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyndamaxTafamidis	103	$3,216,617
CamzyosMavacamten	50	$369,621
EntrestoSacubitril/Valsartan	222	$353,880
JardianceEmpagliflozin	155	$168,929
FarxigaDapagliflozin Propanediol	114	$130,425
EliquisApixaban	45	$56,989
VeltassaPatiromer Calcium Sorbitex	13	$24,259
LokelmaSodium Zirconium Cyclosilicate	22	$20,191
Repatha SureclickEvolocumab	14	$15,322
XareltoRivaroxaban	15	$14,956
Metoprolol Succinate	193	$3,146
Eplerenone	34	$2,840
Spironolactone	291	$2,823
Torsemide	107	$2,785
Carvedilol	237	$2,324

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerVyndamax, Eliquis	$25	$3,273,606148 claims
E.r. Squibb & Sons, L.L.C.Camzyos	$211	$369,62150 claims
NovartisEntresto	$409	$353,880222 claims
AstraZenecaFarxiga, Lokelma	$135	$150,617136 claims
ANI Pharmaceuticals, Inc.Valsartan	$30	$1,48928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.

Other nurse practitioner in Commack

Patricia McGoldrickNew York$202K
Michelle DartSyracuse$95K
Susan KreppelWilliamsville$67K
Kerry AhernEast Syracuse$55K
Valerie StanleyAlbany$55K
Jodi LogerfoNew York$48K
Grace WlasowiczRochester$41K
Melissa LevinElmhurst$34K
Carla JungquistCanandaigua$28K
Kelly WilmarthJohnson City$26K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →